Clinical Trials Browser

Terminated × Bulbo-Spinal Atrophy, X-Linked × Clear all

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

NCT05241613 2025-02-13

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Bulbo-Spinal Atrophy, X-Linked

NCT04869943 2024-01-26

ARTEST

Phase 3 Terminated

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT05673109 2024-01-25

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Bulbo-Spinal Atrophy, X-Linked

NCT03478904 2021-05-10

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Phase 1 Terminated

1 enrolled 8 charts

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02348281 2018-01-23

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Phase 2 Terminated

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT00918385 2014-10-29

ARS

Phase 2 Terminated

57 enrolled 8 charts

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked